NEVVI Medicare utilization intelligence
or

← back

Provider profile

DAITCH, JONATHAN MD

Interventional Pain Management · NPI 1215924154 · FORT MYERS, FL

3
Groups
35
Codes · 2024
13,069
Disclosed services

DAITCH, JONATHAN is a Interventional Pain Management in FORT MYERS, FL, a member of 3 medical groups, who billed 35 distinct codes to Medicare Part B in 2024.

Groups: ADVANCED PAIN MANAGEMENT SPECIALISTS (FORT MYERS, FL) · ADVANCED PHYSICAL THERAPY AND REHAB OF CAPE CORAL LLC (CAPE CORAL, FL) · PHYSIOTHERAPY ASSOCIATES INC (SOUTH DENNIS, MA) — member of 3 groups; the volumes below are this clinician's personal volume and are not attributed to any single group

Year: 2024 · 2023 · 2022 🔒 · 2021 🔒 · 2020 🔒

Provider overview · all codes · CY2024

13,069
disclosed services
35
codes billed to Medicare Part B
Prior year · CY2023 17,856 disclosed services

This provider's disclosed Medicare payments across all codes were in CY2024.

Dollars, place-of-service mix, business mix and national standing are part of the market analytics platform — built, not launched yet. Notify me at launch →

All figures are disclosed (CMS suppresses fewer-than-11-beneficiary rows) Medicare Part B fee-for-service — a subset, never complete totals; volumes are personal to this NPI, not attributed to any group. Standing is a billed-volume position among specialty peers with disclosed billing (national percentile; a provider's true standing can only be higher, never lower), not a statement about care. See Methods & Sources.

Procedures billed to Medicare Part B (2024)

Medicare Part B FFS · CY2024 · as published by CMS
This provider's Medicare volumes — services, beneficiary-episodes, and charges — are part of the market analytics platform — built, not launched yet. Notify me at launch →
CodeDescription Services Beneficiary-episodes Avg charge Avg Medicare payment
J0585 Injection, onabotulinumtoxina, 1 unit
99213 Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
99214 Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
80307 Testing for presence of drug, by chemistry analyzers
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms
64483 Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level
99204 New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more
64484 Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level
64493 Injection of lower or sacral spine facet joint using imaging guidance, single level
64494 Injection of lower or sacral spine facet joint using imaging guidance, second level
64636 Destruction of lower or sacral spinal facet joint nerves using imaging guidance, each additional facet joint
64635 Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint
62323 Injection of substance into lower spine canal using imaging guidance
64634 Destruction of upper or middle spinal facet joint nerves using imaging guidance, each additional facet joint
G0483 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms
64490 Injection of upper or middle spine facet joint using imaging guidance, single level
64633 Destruction of upper or middle spinal facet joint nerves using imaging guidance, single facet joint
27096 Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance
64491 Injection of upper or middle spine facet joint using imaging guidance, second level
20611 Aspiration and/or injection of fluid large joint using ultrasound guidance
62321 Injection of substance into middle or upper spine canal using imaging guidance
64479 Injection of anesthetic and/or steroid drug into upper or middle spine nerve root using imaging guidance, single level
64628 Heat destruction of intraosseous basivertebral nerve in bones of spine in lower back, first two bones
64629 Heat destruction of intraosseous basivertebral nerve in additional bone of spine in lower back
22612 Fusion of spine in lower back
22840 Placement of stabilizing device to back of 1 spine bone in neck
76942 Ultrasonic guidance for needle placement
G0481 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms
0275T Removal of bone from lower spine for decompression of nerve tissue using imaging guidance, accessed through the skin
64480 Injection of anesthetic and/or steroid drug into upper or middle spine nerve root using imaging guidance, each additional level
22513 Treatment of broken middle spine bone with placement of stabilizing device using imaging guidance
22514 Treatment of broken lower spine bone with placement of stabilizing device
22515 Treatment of broken spine bone with stabilizing device, each additional segment
99215 Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more

These are this provider's own Medicare Part B fee-for-service volumes (CMS public data). CMS suppresses rows with fewer than 11 beneficiaries, so low-volume codes may be missing entirely — absence is not zero. Beneficiary-episodes count CMS's per-setting beneficiary figures, not unique patients. Average charge and average Medicare payment are weighted by service volume across office and facility settings. Volumes on this page are personal to the NPI and are not attributed to any physician group. See Methods & Sources.